Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Mourey

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Thrombosis Research|June 5, 2020
Identification and expression of a novel heterozygous frameshift mutation in FGA accounting for congenital hypofibrinogenemia in carriers of severe hemophilia ARui Vilar, Alessandro Casini, Alexandra Fournel, et al.
Biosensors & Bioelectronics|September 7, 2016
Development of a NanoBioAnalytical platform for "on-chip" qualification and quantification of platelet-derived microparticlesSameh Obeid, Adam Ceroi, Guillaume Mourey, et al.
Thrombosis and Haemostasis|April 6, 2012
Correlation between platelet-derived microparticle enumeration by flow cytometry and phospholipid-dependent procoagulant activity in microparticles: the centrifugation step matters!Jérémie Stagnara, Francine Garnache Ottou, Fanny Angelot, et al.
Vox Sanguinis|August 7, 2018
In vitro quality of amotosalen-UVA pathogen-inactivated mini-pool plasma prepared from whole blood stored overnightCatherine Ravanat, Arnaud Dupuis, Nadine Marpaux, et al.
Journal of Clinical Medicine|March 25, 2022
Identification of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients by Using the HIT Expert Probability Score: An Observational Pilot StudyGuillaume Besch, Dejan Ilic, Marc Ginet, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 14, 2021
Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controlsRita Marchi, Marguerite Neerman-Arbez, Valérie Gay, et al.
Current Rheumatology Reports|February 19, 2024
Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and PerspectivesThomas Foret, Virginie Dufrost, Jeremy Lagrange, et al.
The Journal of Investigative Dermatology|July 2, 2013
Increased levels of circulating microparticles are associated with increased procoagulant activity in patients with cutaneous malignant melanomaClaire Laresche, Fabien Pelletier, Francine Garnache-Ottou, et al.
Clinical and Translational Gastroenterology|April 28, 2021
Small Annexin V-Positive Platelet-Derived Microvesicles Affect Prognosis in Cirrhosis: A Longitudinal StudyDelphine Weil, Vincent Di Martino, Guillaume Mourey, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2025
Management of von Willebrand Disease With a Factor VIII-Poor von Willebrand Factor Concentrate: Results From the Paediatric Cohort of a Prospective Observational Post-Marketing StudyJenny Goudemand, Annie Borel-Derlon, Ségolène Claeyssens, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Thrombosis Research|June 5, 2020
Identification and expression of a novel heterozygous frameshift mutation in FGA accounting for congenital hypofibrinogenemia in carriers of severe hemophilia ARui Vilar, Alessandro Casini, Alexandra Fournel, et al.
Biosensors & Bioelectronics|September 7, 2016
Development of a NanoBioAnalytical platform for "on-chip" qualification and quantification of platelet-derived microparticlesSameh Obeid, Adam Ceroi, Guillaume Mourey, et al.
Thrombosis and Haemostasis|April 6, 2012
Correlation between platelet-derived microparticle enumeration by flow cytometry and phospholipid-dependent procoagulant activity in microparticles: the centrifugation step matters!Jérémie Stagnara, Francine Garnache Ottou, Fanny Angelot, et al.
Vox Sanguinis|August 7, 2018
In vitro quality of amotosalen-UVA pathogen-inactivated mini-pool plasma prepared from whole blood stored overnightCatherine Ravanat, Arnaud Dupuis, Nadine Marpaux, et al.
Journal of Clinical Medicine|March 25, 2022
Identification of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients by Using the HIT Expert Probability Score: An Observational Pilot StudyGuillaume Besch, Dejan Ilic, Marc Ginet, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 14, 2021
Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controlsRita Marchi, Marguerite Neerman-Arbez, Valérie Gay, et al.
Current Rheumatology Reports|February 19, 2024
Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and PerspectivesThomas Foret, Virginie Dufrost, Jeremy Lagrange, et al.
The Journal of Investigative Dermatology|July 2, 2013
Increased levels of circulating microparticles are associated with increased procoagulant activity in patients with cutaneous malignant melanomaClaire Laresche, Fabien Pelletier, Francine Garnache-Ottou, et al.
Clinical and Translational Gastroenterology|April 28, 2021
Small Annexin V-Positive Platelet-Derived Microvesicles Affect Prognosis in Cirrhosis: A Longitudinal StudyDelphine Weil, Vincent Di Martino, Guillaume Mourey, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2025
Management of von Willebrand Disease With a Factor VIII-Poor von Willebrand Factor Concentrate: Results From the Paediatric Cohort of a Prospective Observational Post-Marketing StudyJenny Goudemand, Annie Borel-Derlon, Ségolène Claeyssens, et al.
Pageof 3